Prenetics
Hong Kong, HK Β· Public Β· 3 known investors
Prenetics is a health company that operates in genetic testing and precision diagnostics and runs the consumer health supplement brand IM8, sold direct-to-consumer and through Amazon and social commerce channels. The company markets longevity and wellness products globally, including partnerships with athletes and sports organizations.
Also known as NASDAQ: PRE Β· Prenetics Global Limited
Founders & leadership
Investors Β· 3
Company profile
researched Aug 2026Prenetics Global Limited (NASDAQ: PRE) is a consumer health company headquartered in Hong Kong that describes its focus as advancing human health and longevity. Its primary operating business is IM8, a premium daily nutrition brand co-founded with David Beckham as a co-founding partner. IM8's anchor product, Daily Ultimate Essentials, is a 90-ingredient daily nutrition system that the company states is NSF Certified for Sport and clinically studied.
The company originated in diagnostics and genomics. It was founded in 2014 to work on preventive healthcare through accessible diagnostics, scaled COVID-19 PCR testing operations to more than $800 million in revenue over three years from 2020, and listed on Nasdaq in May 2022. Prenetics states that the quality standards developed over roughly a decade in diagnostics and genomics now underpin IM8, and that capital and execution are concentrated on growing IM8 into a global category leader.
Prenetics maintains a scientific advisory board spanning clinical medicine, nutrition, microbiome research and space science, including Dr. Dawn Mussallem (integrative oncologist, Mayo Clinic), Dr. Darshan Shah, Dr. Suzanne Devkota (Cedars-Sinai Human Microbiome Research Institute), Dr. James L. Green (former Chief Scientist of NASA), Dr. James DiNicolantonio, Dr. Amy Shah, Dr. Ara Suppiah, Simon Hill and Dr. Pamela Mehta. The company also references a Bitcoin treasury alongside its investor relations materials.
Business model
Prenetics operates as a Nasdaq-listed holding company whose principal operating business is the IM8 consumer supplement brand, sold through a direct-to-consumer model that the company describes as globally scalable. Athletes and public figures β including David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, Jay Shetty and Inter Miami CF β participate as brand ambassadors and equity partners.
Revenue is generated from sales of IM8 nutrition products, described by the company as recurring/annualized run-rate revenue exceeding $200 million, shipped to 46 countries. Earlier revenue came from diagnostics, including COVID-19 PCR testing.
Traction
Company-reported figures include more than $200 million in annualized run-rate revenue for IM8, $100 million ARR reached within 11 months of the brand's 2024 launch, over 58 million servings delivered, more than 22,100 verified reviews, approximately 200,000 servings delivered daily, and shipping to 46 countries. Prenetics also cites more than $100 million in cash, no corporate debt, and projected revenue of $220-230 million for FY 2026 and more than $400 million for FY 2027.
Latest developments
Press cited by the company includes a July 2025 CNBC interview with CEO Danny Yeung on securing $1 billion in funding to fuel IM8's growth, and April 2026 coverage of Giannis Antetokounmpo taking an equity stake in IM8 and of IM8 reaching approximately $10 million in monthly sales.
βΈFull profile β market position, technology, go-to-market, geography, history
Market position
Prenetics positions IM8 as the fastest-growing premium supplement brand recorded, citing more than $200 million in annualized run-rate revenue within 18 months of launch and roughly 200,000 servings delivered daily.
Prenetics differentiates IM8 through a consolidated multi-ingredient daily nutrition system (90 ingredients in one product), third-party sport certification and clinical study claims, a cross-disciplinary scientific advisory board, and equity-aligned athlete partnerships.
Technology
The company attributes IM8's quality standards to a decade of work in diagnostics and genomics, and describes its formulations as science-backed and clinically studied, developed with input from a scientific advisory board.
Go-to-market
IM8 is marketed through a direct-to-consumer model supported by ambassador and equity-partner relationships with athletes and media personalities, and by science-communication assets such as a scientific advisory board and clinical study claims.
Consumers seeking premium daily nutrition and longevity products, including sports and performance-oriented users (the flagship product is NSF Certified for Sport).
Geography
Headquartered in Hong Kong and listed on Nasdaq in the United States; IM8 ships to 46 countries.
History
Prenetics was founded in 2014 to pursue preventive healthcare through accessible diagnostics. From 2020 it scaled COVID-19 PCR testing, reporting over $800 million in revenue across three years. The company listed on Nasdaq under the ticker "PRE" on 18 May 2022. In 2024 it co-founded IM8 with David Beckham, and has since concentrated its strategy and capital on the consumer health business.
Compiled by commissioned research from 1 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 5
launches, deals, and filingsBloomberg coverage cited by the company reports Giannis Antetokounmpo taking an equity stake in IM8.
CNBC coverage cited by the company reports Prenetics CEO Danny Yeung on securing $1 billion in funding to support subsidiary IM8's growth.
$1B source β
Prenetics co-founded the IM8 premium nutrition brand with David Beckham as co-founding partner; the company reports the brand reached $100M ARR within 11 months.
Prenetics listed on Nasdaq with the ticker symbol "PRE" on 18 May 2022.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 1
primary sources listed
- Preneticsprenetics.com Β· web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Prenetics do?
- Nasdaq-listed Hong Kong consumer health company behind IM8, a premium daily nutrition brand co-founded with David Beckham.
- Who founded Prenetics?
- Prenetics was founded by Danny Yeung.
- Who are Prenetics's investors?
- Prenetics's investors include 500 Global, Beyond Ventures, Gobi Partners.
- Where is Prenetics headquartered?
- Prenetics is headquartered in Hong Kong, HK.